10 Most Trusted Diabetes Solution Providers in 2022V3 2.pdf

Advancing Healthcare
Role of Technology in
Improving Diabetes Care
Health Education
Knowledge, Attitude
and Practices for
Diabetes Care
August
ISSUE 06
2022
®
Welldoc
Delivering 'Just in Time' Care
Kevin McRaith
President and CEO
Welldoc
10
Diabetes
Solution
Providers in 2022
Most Trusted

Be er Health and
a better way of life.

Editor’s
Note
iabetes aﬀects more than 400 million people
Dglobally, and the number of cases is rising. There
are insulin products that are both secure and
eﬃcient. But according to the International Diabetes
Federation, many individuals who need insulin—tens of
thousands of those with type 1 diabetes (T1D) and more
than 30 million with type 2 diabetes (T2D)—do not have
access to a steady supply at a reasonable price.
For vulnerable groups living in low- and middle-income
nations, the situation is particularly bad. Healthcare systems
are frequently not set up to assist the management of this
chronic condition in these populations, therefore patients
and their families must typically foot the bill out of pocket.
Since 2008, diabetes has been included in the Access to
Medicine Index due to the disease's substantial burden.
The World Health Organization is leading a new global
initiative to guarantee that all individuals with diabetes have
access to high-quality care and treatment that is equitable,
thorough, and inexpensive through its 2021 Global Diabetes
Speeding Up
Innovation to Tackle
Diabetes

Compact. One of the most essential areas of eﬀort,
according to the Compact, is to improve access to
diagnostic equipment and medications, notably insulin, in
low- and middle-income nations. The Compact will
establish worldwide coverage targets for diabetes treatment.
The network of public- and private-sector stakeholders
required to deliver a full package of solutions includes the
pharmaceutical corporations that manufacture and supply
insulin.
With a greater emphasis on diabetes care, companies are
coming up with new solutions for better management of
diabetes and encouraging lifestyle changes. From Insulin
pumps, where some insulin pumps administer the
medication continually, while others only do so during
meals or substantial snacks, continuous glucose monitors
where checking your blood sugar before and after meals,
and understand how your diet, activity, and lifestyle aﬀect
your blood sugar levels become much easier, to insulin
innovations which involve rapid-acting, long-lasting, and
premixed formulas that can be delivered via many methods,
such as syringes, pumps, and pens; there are multiple
options for individuals as per their needs today.
In the following edition of Insights Care, "10 Most Trusted
Diabetes Solution Providers in 2022," we highlight ten
such companies that have put forth their innovative foot in
not only tackling the existing health concerns associated
with diabetes, but also easing the lives of patients, and
encourage new lifestyle and healthy habits. These
companies have undergone an intensive amount of research
and development in meeting the objective of a healthy life
and attaining the trust of their customers which has brought
us new hope for a diabetes-free world altogether.
Let's read through to know more!
- Saloni Agarwal

20
Role of Technology in
Improving Diabetes Care
08
28
Knowledge, Attitude and
Practices for Diabetes Care
Health Education
Cover Story
Articles
Welldoc®

Contents
Contents
MiGuide
Lifestyle Medicine Made Easy
14
Pops Diabetes
Care
Augmenting Technology to Enable
Reliable Self-care Space
24 32
U.S. Diabetes Care
of Morristown
The Certiﬁed Excellence
Profiles

Editor-in-Chief
Pooja Bansal
Senior Editor
Anish Miller
Managing Editor
Pooja Shah
Assisting Editors
Saloni Agrawal
Visualiser
David King
Art & Design Head
Mrunalinee Deshmukh
Co-designer
Paul Belin
Art & Picture Editor
Sonia Raizada
Business Development
Manager
Amy Jones
Marketing Manager
John Smith
Business Development
Executives
Sarah Wilson, John Smith,
Alex Vincent
Sales Executives
Kelli, Bill, Anna
Technical Head
Jacob Smile
Assistant Technical Head
Prachi Mokashi
Technical Consultants
David, Robert
Digital Marketing
Manager
Alina Sege
Assistant Digital
Marketing Manager
Renuka Kulkarni
SME-SMO Executives
Gemson
Research Analyst
Eric Smith
Circulation Manager
Tanaji Fartade
Copyright © 2022 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or
transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights success.
Reprint rights remain solely with Insights Success Media and Technology Pvt. Ltd. Insights Care is powered by Insights Success Media and Technology Pvt. Ltd.
August, 2022
sales@insightscare.com
Contact Us:
Follow us on : www.facebook.com/InsightsCare/ https://twitter.com/Insightscare
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - 302-319-9947
Email: info@insightscare.com
For Subscription: www.insightscare.com
Insights Success Media and Technology Pvt. Ltd.
Ofﬁce No. 22, Rainbow Plaza, Shivar Chowk,
Pimple Saudagar, Pune, Maharashtra 411017
Phone - India: 7410033802, 74100058552
For Subscription: www.insightscare.com
We are also available on :

Description
Company Featuring
Person
El Paso Center
for Diabetes
epdiabetes.org
Sandra Gonzalez
CEO
El Paso Center for Diabetes is on a mission to educate
and empower its community to achieve a healthy life
throughout the diabetes journey.
MiGuide
miguide.nl
Arjen Huizinga ,
Rebecca Taylor ,
Bart Brandenburg
CEO, CPO, CMO
MiGuide was founded in 2016 to use smart technology
to help people with type 2 diabetes achieve a better
lifestyle, so that people can take control of their health
and ultimately reduce the need for medication.
Pacific Diabetes
Technologies.
pacificdt.com
Thomas Seidl
CEO
Pacific Diabetes Technologies (PDT) has developed a
hollow glucose sensor that allows insulin infusion and
continuous glucose monitoring (CGM) at a single site
using only a single needle per week.
PanCryos
pancryos.com
Jacqueline Ameri
CEO
PanCryos is dedicated to improve the life quality of
those suffering from diabetes. The company is
developing a next generation stem cell derived cell
therapy PanINSULA.
Phyteau
phyteau.co
Bonn Macy
CEO
Phyteau is developing a safe, new class of incretin
therapy for diabetes, obesity, NAFLD and related
metabolic conditions.
Dorte X. Gram
CEO
PILA PHARMA is a publicly held clinical stage
pharmaceutical company which is developing a
novel type of oral anti-diabetic agent: a TRPV1
antagonist for the treatment of diabetes.
Pila Pharma
pilapharma.com
Lonny Stormo
CEO
Pops offers a consumer-centric solution for self-
management of diabetes. Pops is centered around a
personalized app-based AI virtual coach that is paired
with an easy to use, discreet, smart-glucose meter.
Pops Diabetes
Care, Inc
popsdiabetes.com
US Diabetes Care
usdiabetescare.com
Timothy Keller
Chairman and
Founder
At US Diabetes Care, its team of specialists will
provide the patients with the best care that helps in
the control and treatment of diabetes.
Welldoc®,
Incwelldoc.com
Kevin McRaith
CEO
Driving down the cost of chronic conditions is
going to take all of us. Welldoc is here to help with
BlueStar, our in-app digital assistant for type 2
diabetes.
10 Most Trusted Diabetes Solution Providers in 2022
SERODUS ASA
serodus.com
Eva Steiness
CEO
Serodus is a private Scandinavian drug
development company with a pipeline focusing on
novel, immuno-modulators stopping progression of
diabetic kidney desease.

®
Welldoc
The Welldoc platform provides
meaningful and actionable coaching
and insights to individuals and the
care teams who support them, while
also shifting healthcare to prevention
and optimized interventions and
treatment decisions.
Cover Story

Kevin McRaith
President and CEO
Welldoc

Imagine having access to meaningful health data and
insights, anytime, anywhere, at your fingertips.
Instead of being solely reliant on hospitals, clinics and face
to face office visits, digital health enables new means of
receiving the daily support, education and tools people need
in supporting their health needs.
Welldoc is at the forefront of this digital health
®
transformation. Welldoc's flagship product, BlueStar *, is a
digital health solution aimed at individuals with type 1 and
type 2 diabetes and has 9 FDA 510(k) clearances.
Welldoc has extended its expertise in diabetes to now offer
a multi-condition digital health solution across diabetes,
pre-diabetes, hypertension and heart failure, with built-in
behavioral health support, a necessary element to helping
individuals throughout their chronic care journey. With its
mission of integrating personalized, real-time, and
actionable AI-driven insights into the daily lives of
individuals living with chronic conditions, Welldoc is not
only focused on helping people take control of their
conditions, but also on ensuring that these insights are
connected to existing care models to support the right
interventions and clinical decisions.
However, as digital health solutions proliferate, attempts to
incorporate Artificial Intelligence (AI) and Machine
Learning (ML) into healthcare have been met with various
degrees of success. Welldoc's advanced AI is the critical
engine behind the analytics, insights, and shared decision-
making between individuals and their care teams and it
works.
Welldoc has been blessed by dynamic and passionate
leadership. As President and CEO, Kevin McRaith leads
the Welldoc team to develop and commercialize innovative
digital health solutions for people living with chronic
disease(s).
Kevin has more than 25 years of experience in the life
sciences sector, including biotech, pharmaceuticals, hospital
supplies, and digital health.
Before joining Welldoc, he held senior executive roles at
Human Genome Sciences, Genentech and Abbott after
starting his career at Baxter Healthcare.
*Welldoc Diabetes Rx/OTC is an FDA-cleared medical
device ("BlueStar"), intended for use by healthcare
providers and their adult patients with type 1 or type 2
diabetes. For full labeling information, visit. The other
Welldoc products are non-FDA-cleared and intended to
promote general wellness and education/self-management
of various chronic disease states.
1
Ÿ Shomali M, Peeples M. Implementation strategy for a
digital health tool influences user engagement.
Diabetes. 2018;67(Suppl 1):1320-P. doi:10.2337/db18-
1320-p
All-inclusive and Broad Platform
Welldoc's advanced AI connects and leverages an
individual's health data across six dimensions of
health—medications, labs, diet, activity, symptoms, and
psychosocial factors—to seek meaningful correlations to
inform real-time digital coaching, personalized insights and
care team support.
The Welldoc Platform includes Welldoc's flagship product,
BlueStar, an FDA-cleared digital health solution, guides
individuals through the complicated journey of living with
diabetes by enabling them to self-manage their care while
enhancing connections to their healthcare team.
The Welldoc Platform includes:
Ÿ An AI-driven digital coaching app providing
personalized, actionable guidance throughout an
individual's chronic care journey
Ÿ Reporting and workflow integration enabling care teams
to easily access data insights to inform clinical
interventions and decisions
Ÿ A Management Portal providing care management with
enhanced population-level health data and analysis
Ÿ Connectivity to more than 400+ devices and data
sources, including fitness trackers, glucose monitors,
blood pressure cuffs and weight scales, to allow
individuals to leverage the tools they already utilize, and
ensure multiple dimensions of health (medications,
symptoms, activity, psycho-social, individually
generated data and labs) are connected to power
Welldoc's advanced AI engine
10 Most Trusted Diabetes Solu on Providers in 2022

Outstanding Oﬀerings
Welldoc's comprehensive chronic care platform is backed
by evidence and years of regulatory expertise. The chronic
care platform brings ﬁrst-in-class clinical, tech and
advanced AI expertise, as demonstrated by Welldoc's 60+
clinical posters and publications, 25 patents, and 9 510(k)
FDA clearances for BlueStar.
Welldoc also believes that partnership is the pathway to
better management of chronic conditions. Digital health
solutions do not work in a silo, and data and insights should
be integrated into care models to truly support optimized
interventions and clinical decisions.
Welldoc collaborates directly with health plans, health
systems and employers to extend care, improve health, and
reduce costs. Its extensive research has shown:
Ÿ Average cost savings of $3,048-$3,252/person with
2
Type 2 diabetes, annually
Ÿ A 1.2-2.0 point mean A1C reduction in individuals
3,4
living with type 2 diabetes
Ÿ A Net Promoter Score (NPS) indicating +10 higher
consumer satisfaction compared to competitors
Moreover, Kevin stated, "Welldoc is building more
comprehensive chronic care programs, focused on
Welldoc's
comprehensive chronic
care platform is
backed by evidence
and years of regulatory
expertise.

prevention, self-management, connected care, and total
health."
2
Ÿ IBM Watson Health. Estimating the economic value of
a digital therapeutic in type 2 diabetes. Welldoc-
sponsored report 2018. Published August 2018.
3
Ÿ Tang PY, Duni J, Peeples MM, et al. Complementarity
of digital health and peer support: "This Is What's
Coming." Front Clin Diabetes Health. 2021;2.
doi:10.3389/fcdhc.2021.646963
4
Ÿ Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr
EA, Gruber-Baldini AL. Mobile Diabetes Intervention
for Glycemic Control. Journal of Diabetes Science and
Technology. 2014;8(2):362-370.
doi:10.1177/1932296813514503
Adoption of Modern Technologies
As a trailblazer in digital health, Welldoc has ﬁrst-hand
knowledge of what it takes to truly impact the adoption of
AI-driven digital health and make it part of an updated
standard of care.
Ÿ Seamless Integration into Daily Life : Welldoc's app,
as shown in its high customer satisfaction scores,
provides people with simple, easy to use tools to
connect and manage multiple aspects of their health,
like nutrition and activity, while also leveraging this
data to deliver personalized AI-driven digital coaching.
This helps build awareness while encouraging a
healthier lifestyle every step of the way.
Ÿ Rigor and Regulatory Expertise: Incorporating and
optimizing AI into digital health solutions requires
clinical rigor and regulatory pathways to ensure quality,
safety, and eﬀectiveness. Welldoc's regulatory expertise
provides the unique ability to apply advanced AI and
Machine Learning to its solution.
Ÿ Actionable Insights: Data must be translated into
meaningful and actionable insights informing individual
behaviors and supporting clinical interventions and
treatment plans. This ensures Welldoc's AI is truly
supporting a change from reactive to prevention-based
care.
Propelling dynamic
and insightful
connected chronic
care across the globe
is central to Welldoc's
mission.

Ÿ Care Integration: AI approaches cannot exist separate
and siloed from care. For AI-driven insights to be
appropriately leveraged to optimize interventions and
clinical decisions, they must be integrated into existing
care models. Welldoc does not just provide a digital
health solution, but rather it partners closely with
healthcare leaders to ensure seamless integration into
existing workflows. The company recognizes that
healthcare is a vastly complicated ecosystem, and
without deep partnerships, no amount of data will be
impactful enough to create meaningful, longitudinal
change.
A Multifaceted Approach
Ÿ Globalization: Propelling dynamic and insightful
connected chronic care across the globe is central to
Welldoc's mission. The flexibility and scale of its digital
health platform enable integration into all types of
healthcare models worldwide. Over the next three years,
the company plans to expand commercialization beyond
the US and Canada, into both Asia and Europe.
Ÿ Chronic Care Expansion: Welldoc will continue to
integrate offerings for new chronic conditions and
comorbidities into the platform based on the needs of
individuals and the entirety of its user population.
Currently, the platform supports AI-driven digital
coaching across prediabetes, type 1 and type 2 diabetes,
hypertension, and heart failure.
Recent updates have included the addition of an
integrated behavioral health component to provide
wraparound support to help sustain behavior change and
a new tailored digital coaching experience for those with
multiple chronic conditions.
Ÿ Increased Regulatory Clearances and Patents:
Welldoc will extend its capabilities to support and
manage complex chronic conditions by expanding its
regulatory clearances in collaboration with its strategic
partners.
Additionally, Welldoc remains committed to scientific
research and growing its library of 60+ publications and
posters in support of the value of digital health, its use in
approaches to chronic care, and driving value across
healthcare. It will further advance research efforts in
multi-digital health engagement, artificial intelligence,
cardiometabolic condition outcomes, cost and value,
and real-world integration into the health ecosystem.
Welldoc also continues to pursue new patents associated
with its first in class technology and AI, beyond the 25
already granted.
Ÿ Achieving Scale: It has become increasingly difficult to
provide consistent and sufficient care across an aging
complex care population due to resourcing shortages in
healthcare, exacerbated by the COVID epidemic.
Additionally, social determinants of health (SDOH) are
contributing to wide health disparities and inequities
across a growing, diverse population living with chronic
conditions.
Welldoc believes that the digital health solution is critical to
scaling and extending care beyond traditional means, while
also having an impact on the ~$2 trillion spent on diabetes
and cardiovascular conditions.
It continues to expand the partnerships with leaders and
innovators in healthcare to achieve this scale in real-world
settings. The Welldoc platform provides meaningful and
actionable coaching and insights to individuals and the care
teams who support them, while also shifting healthcare to
prevention and optimized interventions and treatment
decisions.
5
Waters H, Graf M. The Cost of Chronic Disease in the U.S.
Milken Institute; 2018. Accessed September 16, 2021.
https://milkeninstitute.org/sites/default/files/reports-
pdf/ChronicDiseases-HighRes-FINAL_2.pdf
An Advice Worth Noting
When giving a note of advice, Kevin states, "Staying true to
your mission in the constantly evolving digital health
industry requires an extraordinary amount of patience and
resilience.”
He further continues, "You must continue understanding
and adapting to the healthcare landscape to meet the needs
of individuals, but also ensure your solution can be
integrated into real-world settings and the dynamic
healthcare market."

MiGuide
Lifestyle Medicine Made Easy
ehavioral Change! A phenomenon that is quite
Bobserved, exhibited and witnessed in different
species relating to mammals. And, as being the
most intelligent species on the planet, humans have evolved
along with the progression of this phenomenon into the
socio-psychological realm.”
This iteration might sound very specific to the community
who are into biophysiologics of the healthcare system. But,
this theoretical underpinning doesn't just stop there. With
technological up-gradation and the emergence of
biomedical devices, it has been very easy to take an in-
depth understanding of human health, and with advanced
technologies like AI and ML, there are many entrepreneurs
and healthcare enthusiasts who are providing effective
solutions and are facilitating diabetes solutions services
as—this biological disorder of pancreas and its symbiotic
organ system has a lot with the human behavioral pattern.
One such company whose services stand on the
fundamental fusion of behavioral change inputs and big
data insights is MiGuide.
“We want to support patients and professionals with
lifestyle medicine so both experience the benefits of lasting
lifestyle changes,” says the company's Chief Executive
Officer—Arjen Huizinga.
Spearheading this transformation is a trio who are at the
heart of the organization.
Below are the interview highlights that bring the viewpoints
of the top management brass of the organization—Arjen
Huizinga| Chief Executive Officer—Rebecca Taylor|
Chief Product Officer—Bart Brandenburg| Chief
Medical Officer.
Let's slide into the interview and learn how did MiGuide
make it possible to become one of the most trusted diabetes
solution providers with its MedTech Solution.
Please brief our audience about your company, its USPs,
and how it is currently positioned as one of the most
reliable companies providing diabetes solution in the
healthcare sector.
MiGuide is a combined MedTech developer and digital-first
healthcare clinic specialized in blended-care lifestyle
coaching, based in Rotterdam, The Netherlands. Founded in
2018, our mission is to improve quality of life and health
outcomes for patients with chronic conditions, such as type
2 diabetes.
MiGuide is based on behavioral change theory, where small
steps, which you have control over, lead to big changes.
These are informed by personalized insights from 'big data'
analysis and supported by healthcare professionals, with
General Practitioners and lifestyle coaches informed via the
MiGuide platform.
- 50% of the perceived burden of disease in chronic
conditions can be attributed to an unhealthy lifestyle and
improving lifestyle is effective
- Making (and maintaining) lifestyle adjustments is
difficult, stretched healthcare providers do not have the
bandwidth to build into their care process without support
- MiGuide mobilizes and supports patients' own intrinsic
motivation with “blended” guidance, a framework for
both patients and care providers.
“
August 2022
14|www.insightscare.com

The aim of MiGuide is to
ensure that patients learn
what a healthy lifestyle is and
what they can do, at their own
level, to change their lifestyle.
Self-management and
self-direction is essential: by
having this foundation, the
patient can maintain a healthier
lifestyle on their own.
Arjen Huizinga
Chief Executive O cer
MiGuide
Rebecca Taylor
Chief Product O cer
MiGuide
Bart Brandenburg
Chief Medical O cer
MiGuide

Our core differentiator, next to an impactful behavior
change service, is that MiGuide is a platform for patients
and general practitioners. The app is connected to all the
general practitioner information systems in the Netherlands,
so the patient has access to his own medical file. Vice versa,
the General Practitioner may view the patient's self-reported
data. Gaining insights into the patient's diet and exercise
pattern, data that helps prepare the next consultation,
possibly concluding that this consultation is no longer
necessary.
We are the digital extension of the General Practitioner.
Tell us more about your company, its offerings, and its
stronghold in the healthcare space.
Maintaining a healthy lifestyle can have a major positive
impact on health. It is difficult for patients to adopt this
healthy lifestyle because it requires a change. Their current
way of life is often deeply embedded and is tied to habits,
culture, upbringing, the environment, and many other
factors. If these issues are not addressed, a different lifestyle
may not be achieved.
Diabetes is a serious disease characterized by high blood
glucose levels. About 1.2 million in the Netherlands alone,
and this number is growing by about 1200 people every
week, including young people, partly due to the prevalence
of overweight. In Western countries, type 2 diabetes is two
to five times more common among people with low
education and with a migration background. Diabetes often
leads to long-term complications such as cardiovascular
problems, nerve damage, eye problems, foot ulcers, and
chronic kidney disease. Patients with diabetes are more
vulnerable to infections such as COVID-19. For the patient,
this means a reduced quality of life and a reduction in life
expectancy.
To improve these outcomes, MiGuide created the MiGuide
lifestyle platform for patients with diabetes and their care
providers. The MiGuide platform is aimed at guiding
diabetes patients to change their lifestyles and behavior in a
sustainable way.
The app is a (digital) personal coach for the patient. In the
app, patients are coached on exercise, nutrition, and
medication. This allows the patient to set exercise and
nutrition goals. For each goal, the patient is given
challenges to achieve that goal every day in small steps and
will then be coached on this.
The uniqueness of the platform is that it is a specialist
"open" care platform, which is integrated with General
Practitioner's information systems and easy to integrate and
connect with other care systems.
MiGuide has the following functionalities around Lifestyle
coaching:
- Linked to NHG (Dutch College of General Practitioners)
guidelines
August 2022

- Linked to patients' medical files with all General
Practitioner information systems used in the Netherlands
(including CGM, ), the market leader in Germany).
- Exercise module
- Food diary with > 50.000 items
- Individual care plan, goals and target values
- Digital knowledge base for all questions about diabetes
and lifestyle
- Consult preparation to guide consultation and to reduce
no-shows
- Access to medical file to increase insight
- Filling in measurement values to enable self-
measurements
- Notifications to activate patients
What are the core values upon which your organization
is built?
Our mission:
“Supporting patients and professionals with lifestyle
medicine so that both experience the benefits of lasting
lifestyle changes”
Our core values:
Ÿ Patient driven
Ÿ Trustworthy
Ÿ Optimism
Ÿ Freedom
Being an experienced leader, share your opinion on how
the adoption of modern technologies has impacted the
healthcare industry and how is your company adapting
to the change?
We believe that, considering the complexity of the field and
the immaturity of the field, finding the right product market
fit for life style change is the key factor for Diabetes
lifestyle companies like MiGuide. So we have to be flexible
and lean - focused on the wishes and requirements of the
patient. We must support the patient journey. Enrich the
patient journey through proven behavior change
methodology. And following our ethos, optimism, it should
be a positive and social experience.
Considering the example of the COVID-19 pandemic,
how do you plan to navigate through similar situations
in the future?
Digital-first is the key. The aim of MiGuide is to ensure that
patients learn what a healthy lifestyle is and what they can
do, at their own level, to change their lifestyle.
August 2022

Self-management and self-direction is essential: by having
this foundation, the patient can maintain a healthier lifestyle
on their own.
MiGuide also aims to reduce the workload of general
practitioners and their assistants. By gaining more insight
into the patient, a practice can 'choose' which patients need
a consultation and which may be doing fine without. In
addition, consultations are shorter and more efficient:
conversations are substantiated with data from the app and
patients can prepare their consultation and send it to the
practice.
As an established industry leader, what would be your
advice to the budding entrepreneurs and enthusiasts
aspiring to venture into the healthcare sector?
For society healthcare consumption and aging populations
is an enormous drain on governmental budgets.
The core of the solution should add efficiency and be cost
effective to scale . In order to achieve this long-term plan,
an understanding of the healthcare sector with its financial
payment flows and interests is important. The interests of
these parties, next to the patient, are key to success.
How do you envision scaling your company's services in
2022 and beyond?
Our core strategy is to be a scalable data-driven company
supporting self-management.
The annual costs of diabetes in the Netherlands are around
6.8 billion euros, of which about 25% in healthcare costs.
The other costs are mainly related to labor market
participation in terms of absenteeism, disability and loss of
labor productivity, which are greater for patients with
diabetes than the general population. Given the increasing
number of patients, the costs will only increase
exponentially in the coming years.
The current size, increasing number of patients, and
associated costs are clear indications that current
approaches aren't enough. The healthcare sector also has to
deal with a shortage of labor in the coming years.
Current care is reactive; a patient receives professional help
if there are problems, it is labor-intensive, it is mainly
organized face-to-face, and has too much 'one size fits all'
approach while the onset, perpetuating factors, and the
course of the disease for every patient is different. On the
one hand, this is caused by the lack of good technological
solutions to be able to provide care in a sufficiently
personalized way and also outside the walls of the care
institution, but also the system in which innovations have to
be adopted and implemented is insufficiently developed.
Please give us a few testimonials of your
clients/customers and a list of awards/recognitions that
accurately highlight your organization's position in the
market.
“The positive approach (assuming what CAN be done) of
the coaching is a real plus.” - Marco Hazebroek, participant
MiGuide lifestyle coaching
“A great learning moment is learning to divide it into small
pieces and celebrate what you have achieved. That's so
important. If you set huge goals or want to achieve
everything in one go, it becomes almost unattainable.”
- Marco Hazebroek, participant MiGuide lifestyle coaching
“It's about the power of those two, the lifestyle coach and
the app and realizing why you do things.” - participant
MiGuide lifestyle coaching pilot Grip on Diabetes
“I really benefit from the MiGuide app. It helps you achieve
goals related to nutrition and exercise.” - Wout van Zeeland,
participant MiGuide lifestyle coaching
“The strength of the group sessions is the transfer of
knowledge and the interaction between the participants
where tips and experiences are shared.” - Don Bethume,
participant MiGuide lifestyle coaching
“By participating in this program I lost weight and now I
don't have to take medication for my diabetes” - Tiny van
Raaij, participant MiGuide lifestyle coaching
“By filling in the food diary, I sometimes get scared of how
many calories are in something. So I'm pressed against the
facts. And that helps!” - Tiny van Raaij, participant
MiGuide lifestyle coaching
Supporting patients and
professionals with lifestyle medicine
so that both experience the benefits
of lasting lifestyle changes.
August 2022

Diet Ce
Tenology
in Improving
Role of
Diet Ce
Diabetes mellitus is becoming more common in the
world at an alarming rate. The World Health
Organization (WHO) urges strengthening of the
health system's response to this chronic illness in its first
global report on the disease because diabetes and its
complications can result in significant financial losses for
those who have the disease, their families, health systems,
and national economies.
Technological advancements hold great promise for
addressing unmet needs in the area of diabetes care. Recent
developments in diagnostics, information technology,
nutrition, and food technology have fundamentally changed
how we approach comprehensive diabetes care.
August 2022

Over the past 30 years, there have been enormous
technological advancements in the management of diabetes.
The technologies that are most frequently reported deal
with the needles and injections needed to give insulin and
the tools required to control blood sugar and avoid long-
term consequences.
Capillary glucose metres/self-monitoring blood glucose
Although capillary glucose metres have been in clinical use
since the 1960s, it wasn't until the 1990s that they began to
be utilised widely as a result of technological advancements
that reduced the cost of the metres and the reagent strips. At
costs that are equivalent to or even less than those of
venous plasma glucose estimates, the most recent glucose
metres deliver readings that are comparable in accuracy.
Self-monitoring of blood glucose has become a crucial
component of diabetes management, particularly for
patients who are using insulin, thanks to the development of
affordable metres and strips. Although it is not advised in
the clinical environment to utilise capillary glucose metres
to diagnose diabetes, it may be the only practical method in
large epidemiological studies, particularly in resource-poor
regions of the world.
Point-of-care glycated haemoglobin testing
As an alternative measurement for the level of circulating
glucose over a period of 120 days, the concentration of
glycated haemoglobin (HbA1c) is used. It is used as a
clinical tool for monitoring glycaemic control in persons
with diabetes since it is a marker of problems linked to
diabetes.
Point-of-care testing (POCT), as an alternative, promises to
deliver immediate findings at the moment of patient
consultation. A drop of capillary whole blood obtained
using the finger-prick method is used by POCT devices to
measure HbA1c. Within a few minutes of administering the
blood to the test cartridge, the sample is analysed.
Insulin Infusion Pump
For insulin therapy to be effective, patients must both have
type 1 diabetes and many cases of type 2 diabetes. Despite
the enormous progress made in insulin therapy over the past
three decades, the majority of patients using insulin still
have inadequate glycaemic control. The fact that the insulin
regimens currently in use do not perfectly replicate the
normal production of insulin from the beta-cells of the
pancreas is a fundamental factor in this dilemma. The CSII
pump is an effort to provide people with diabetes insulin in
a more natural way, preventing the highs and lows in
insulin levels caused by several subcutaneous injections.
Insulin pens
Insulin pens are more practical because they don't require
writing up a dose. Increased precision and dependability
result from the capacity to dial up the necessary amount,
particularly for low doses that are frequently required in the
elderly. Many pens have dial mechanisms that provide
sensory and audible input, which is helpful for people who
are blind or visually impaired. Additionally, pen devices are
smaller, lighter, and easier to hold.
Contrarily, insulin pens are more expensive than insulin
vials. Patients could also discover that using pen devices
takes longer because the needle needs to stay in the
subcutaneous tissue for five to ten seconds after the dose is
released. Additionally, not all insulin types are offered in the
pen device.
Wrapping Up
Vast advancements in medicines, information technology,
diagnostics, and drug delivery during the past two decades
offer the potential to simplify and reduce the cost of
managing diabetes and associated complications. It should
be kept in mind, though, that every tool or piece of
technology is only as good as the person using it. The
willingness of patients and healthcare professionals to adopt
and fully utilise these technology advancements will be
crucial to their success. The initial cost of adopting these
technologies may be a significant obstacle in low- and
middle-income nations and has to be investigated.
-Saloni Agrawal
August 2022

Pops Diabetes
Care Augmenting Technology to Enable
Reliable Self-care Space
Isn't it convenient to have your own personal virtual
coach that will help you track goals and be a pep of
encouragement in your back pocket?
That's the potential of AI when it's integrated into the health
care niche. Research suggests that AI can perform as well
as, or better than humans at key healthcare tasks, especially
in diagnosing diseases.
Putting it simply, virtual services are effective and
convenient due to the range of benefits they offer. One such
virtual health assistant 'Mina' launched by Pops Diabetes
Care is very popular among people with diabetes.
Alongside Mina, the company is catering to a growing
ecosystem of services, education, sensors in order to reduce
barriers to optimal health. Delivering this range of services
effectively, Lonny Stormo, CEO, believes in creating
solutions to help manage people's health.
In an interview with Insights Care, Lonny talks about Pops
Diabetes Care and how the company is catering to the
needs of the healthcare niche.
reliable companies providing diabetes solutions in the
healthcare sector.
Pops, the Own Your Life® company, has commercialized
an AI Self-care platform for chronic condition management,
starting in the diabetes space. Pops provides individuals the
resources to enable them to successfully care for themselves
versus being remotely monitored. The platform is centered
around Mina, an AI Virtual Health Assistant. Mina is built
on proven medical science.
She uses the Transtheoretical Model of Change to assess
how ready a person is to change healthcare behaviors, and
her goal is to move you into maintenance. She assists in
behavior change through Motivational Interviewing; a
technique used for many years to help people make better
healthcare choices.
All the solutions around Mina are curated to address
specific reasons people say they cannot reach their diabetes
goals. The number one barrier people state is not liking to
test their blood sugar. The Pops Rebel meter is the simplest
way to check blood sugar. The Rebel is 20% the size, very
discreet, and less painful compared to glucose test kits.
The complete platform is sold as a subscription service for
both D2C and B2B (through clients like Best Buy Health).
It is being used in all 50 states and in Australia and has been
published with positive clinical study outcomes.
Where the traditional healthcare industry sees non-
compliant patients that need to be monitored and managed,
we see people that have not been given the tools and
experience they need to manage their condition. So many
other industries have successfully democratized into
individual consumers' hands through technology. People
are no longer dependent on a travel agent to travel or on a
banker to do their banking. Today, people can manage
travel and banking themselves. Pops is a leader in enabling
people with chronic conditions to do the same.
With the Pops' Self-care platform, people with diabetes can
manage their condition more successfully between their
physician visits. In fact, our two years clinical study results
August 2022

demonstrated a sustained A1c (the clinical measure of blood
sugar) drop of 1.3 points. This study outcome was
published in January 2022 in the International Journal of
Digital Health.
Additional sub-analysis in this study showed that 21 people
had a baseline A1c above 7.0%, which is the level the
American Diabetes Association recommends staying below.
Those 21 people had an average baseline A1c of 10.1%,
which means they were choosing not to manage their
diabetes with current solutions. Over the two years of using
Pops, they were able to drop their average A1c by 33% to
an average of 6.8%.
These results show us that a better self-care solution is a
viable alternative to patient management. Simpler self-care
is what Pops provides to people with diabetes.
is built?
Our tagline, which is a key element of our mission, is “Own
Your Life®”, and I think this sums up what Pops is about in
three simple words. We are not going to take care of you.
Healthcare for chronic conditions can be more successful
when we enable people vs monitoring and manage them as
patients. In fact, we drive this home every day in our
company by not allowing the word “patient” to be used.
When people start owning their life by using the Pops Self-
care platform, we refer to them as Owners.
We accomplish letting people take charge of their lives at
Pops by constantly emphasizing that “It is all about the
experience”. Nobody is motivated to be unhealthy. It is
only a matter of how high of barriers they are willing to
jump over to get healthy. If we lower the barriers that exist,
more people will choose to manage their health. That is a
key premise of what we do. From how our app works to
how we ship products, the user experience is in the front of
each employee's mind. This is especially important for the
management of chronic conditions like diabetes because
managing a condition like diabetes is a marathon versus a
sprint. We need to keep people engaged through the entire
marathon.
Lonny Stormo
August 2022

healthcare industry and how is your company adapting
to the change?
So many other industries have successfully democratized
their offerings into consumers' hands through technologies
available in our phones. People are no longer dependent on
a travel agent to travel or on a banker to do their banking.
This megatrend of democratization is now happening in
healthcare. This first started about ten years ago with the
advent of activity trackers people began to wear and use to
count steps. Both the advancement of people's desire to take
more control of their health and the availability of
technology have accelerated this megatrend. We see people
buying wearables to monitor everything from their heart
rate variability to their brain waves. The mobile health
industry is projected to grow 30% CAGR over the next
eight years.
Figure out your own unique way to sell your solution. It is
not good enough to just have a better solution. The entire
industry--from reimbursement to employer benefits plans--
is set up to reinforce the current standard of care. This
makes it very difficult for a new player to come in and try to
sell even a “better” solution.
An entrepreneur needs to look at how their solution can
create a unique selling proposition. Then the entrepreneur
needs to break down the planned sales category into a very
honed and specific set of target customers to more likely
help the customer to understand the unique value
proposition for them.
2022 and beyond?
The Pops Self-care platform will evolve in two important
directions. We will add more ecosystem partners around
Mina to remove more barriers for people managing their
diabetes and other chronic conditions. We have developed
a list of barriers that people tell us to get in their way of
managing their condition.
Our ecosystem partners are selected to eliminate those
barriers. Don't know what vitamin you should take? Mina
will connect you to our ecosystem partner, Vous Vitamin.
Don't like to grocery shop for healthy foods? Mina will
connect you to Sunbasket food delivery. As we discover
additional solutions, we will integrate those into Mina and
our ecosystem.
Secondly, Pops is scaling the platform into chronic
conditions related to diabetes, including weight control,
hypertension, and hyperlipidemia. New best-in-class
sensors (e.g., blood pressure cuffs) will be added, along
with new content for Mina to help people self-manage these
conditions.
Simpler
self-care
is what Pops
provides to
people with
diabetes.
August 2022

Stay in touch.
Subscribe to Insightscare Get Insightssuccess
Magazine in print, & digital on www.insightscare.com
Never
Miss
An
Issue
Subscribe
Today
Corporate Ofﬁce
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin,OH 43017, United States
Phone - (614)-602 - 1754,(302)-319-9947
For Subscription : www.insightscare.com
Check should be drawn in favor of :
INSIGHTS SUCCESS MEDIA TECH LLC
www.insightscare.com

Diabetes
Care
Knowledge,
Attitude and
Practices for
Awareness is necessary for managing diabetes.
Understand the daily elements that cause your
blood sugar to climb and fall, and learn how to
manage them. Often, it can be hard to maintain your blood
sugar levels within the range that your doctor has advised.
This is due to the numerous factors that might trigger
sudden changes in your blood sugar levels.
The following are a few things to know that can have an
impact on your diabetes.
Eating Healthy
Healthy life, whether or not you have diabetes, starts with
good nutrition. You must understand how foods impact your
Health Education
August 2022

blood sugar levels if you have diabetes, though. Not only is
it what you eat, but also how much you consume and the
combinations of different food kinds you consume.
Learn about portion control and counting carbohydrates.
Learning how to measure carbohydrates is a crucial
component of many diabetes control strategies. Your blood
sugar levels are frequently most impacted by carbohydrates.
Knowing how many carbohydrates are in your diet will
help you get the right dose of insulin if you take mealtime
insulin. Find out the proper serving size for each type of
food. By noting the serving sizes for foods you eat
frequently, you can make meal planning easier. To
guarantee adequate portion size and a precise carbohydrate
count, use measuring cups or a scale.
Every meal should be well-balanced. Plan each meal to
include a healthy balance of carbs, fruits and vegetables,
proteins, and fats. Be mindful of the kinds of carbohydrates
you select. Certain sources of carbs, such as those found in
fruits, vegetables, and whole grains, are healthier than
others. These meals provide fiber to help keep your blood
sugar levels more steady and are low in carbohydrates.
Discuss the greatest dietary options and the ideal balance of
food kinds with your doctor, nurse, or nutritionist.
Exercise
Another crucial component of your diabetes control
strategy is physical activity. Your muscles use sugar
(glucose) as energy while you work out. Your body uses
insulin more effectively when you exercise frequently.
Together, these elements lower your blood sugar levels. The
duration of the impact increases with the intensity of your
workout. However, even simple tasks like housework,
gardening, or standing for extended periods of time might
lower your blood sugar.
Set aside time to exercise. Consult your doctor about the
optimum time of day to work out so that it coincides with
your eating and medication regimens.
Understanding numbers: Before you start exercising,
discuss with your doctor what blood sugar levels are
suitable for you.
Check the level of your blood sugar. Before, during and
after exercise, especially if you take insulin or other
medications that lower blood sugar, check your blood sugar
level. Exercise can drop your blood sugar levels even up to
a day after you exercise, especially if you're trying a new
activity or exercising more vigorously. Be on the lookout
for low blood sugar warning signals, such as feeling jittery,
weak, weary, hungry, lightheaded, or angry.
Stress
Your blood sugar may rise if you're anxious because of the
hormones your body creates in reaction to ongoing stress.
Furthermore, if you're under a lot of additional stress, it
could be more difficult to strictly adhere to your regular
diabetes care routine.
Analyse patterns: At the same moment that you record your
blood sugar level, rate your degree of stress on a scale of 1
to 10. There might soon be a pattern. Take charge: Take
action once you are aware of how stress impacts your blood
sugar level. Establish limitations, prioritize your tasks, and
learn relaxation techniques. Always try to stay away from
typical stressors. Exercise frequently assists in lowering
blood sugar and relieving tension. Get support: Discover
fresh coping mechanisms for stress. Working with a
psychologist or clinical social worker may be able to help
you recognise stresses, discover solutions to difficult issues,
or develop new coping mechanisms.
Conclusion
The more you are aware of the variables that affect your
blood sugar, the better you will be able to predict changes
and make plans accordingly. Ask your diabetes healthcare
team for assistance if you're having problems maintaining
your blood sugar level within the desired range.
-Saloni Agrawal
August 2022

With a need to walk with the running time,
humans have been compromising on their
health, which very predictably has led to
several health issues and constantly revolving concern
around it. Change and stress combined have fathered many
lifestyle diseases and increased the prevailing ones; the
most common ones of these are Diabetes, Stroke,
Alzheimer's and mental health issues.
Nearly 537 million people worldwide are diagnosed with
Diabetes, which is approximately 10% of the world's
population. With an estimated increase in the number of
patients in the future, it is important to treat Diabetes as it is
potential damage to the human system and having no cure
for it makes it more fatal.
Fortunately, the time has also bought evolution in the
healthcare sector leading to the creation of organizations
specializing in treating diseases. One such organization is
U.S. Diabetes Care of Morristown, the only Diabetic
center certified by the CDC. Timothy Keller, Chairman,
and Founder of U.S. Diabetes Care of Morristown being a
diabetic himself realized the need for proper diabetes care
in the health care industry and created the organization on
principles of Love, Hope, and Family.
Let's delve into Timothy's interview and learn more about
U.S. Diabetes Care of Morristown:
reliable companies providing diabetes solutions in the
healthcare sector.
We are proud of the fact that we are the only trained
Diabetic treatment center in the area. Our staff is skilled in
both the education and treatment of Diabetes. Focusing on
just Diabetes allows us the time with patients to help them
understand their diagnosis. Patients are given the tools they
need to understand that it is not just medication, exercise
and food intake.
Our team understands that every diabetes diagnosis is
unique. We spend time getting to know our patients, their
environment, family life and stressors so we can provide the
individualized care and support that they deserve. In
addition, we do not receive the credit for HEDIS quality
measures or shared savings. Therefore, we will do the work
for the primary care provider for the diabetic's health, and
the primary care provider receives the credit for the
measure and shared savings, and the diabetic receives
focused quality diabetic health care.
We provide unique individualized care to our diabetic
patients. We treat patients aged ten years and above. No
referral is needed as we work with the patient's primary care
provider to coordinate care. Not only are we a benefit to
patients, but at the same time, we provide a benefit for the
Primary Care Providers. By sending their patients to use,
we can meet the A1C Quality metric goals set by HEDIS
for the primary care provider. This allows the primary care
provider more time to focus on and treat the other quality
measures that must be met for the patient.
is built?
Our core values are based on our basic logo for U.S.
Diabetes Care, which is Love, Hope & Family.
U.S. Diabetes Care
of Morristown
The Certified Excellence
August 2022

healthcare industry and how your company is adapting
to the change.
Today is the most exciting time in healthcare. New
technologies emerge routinely, allowing a better
understanding of diseases and patients' disease states. New
technologies allow taking a glucose reading without the
need for painful finger sticks. Tracking and monitoring the
patient's blood glucose readings by downloading the data
via a smartphone or computer is just the beginning. We
constantly research the latest technology for our patients
that will improve their quality of care and lifestyle. We
currently utilize Vital Scan testing and the cutting-edge
'Neural scan', which were simply unheard of until recently.
We can only imagine what is on the horizon for diabetic
evaluation.
Considering the example of the COVID-19 pandemic,
how do you plan to navigate through similar situations
in the future?
Obviously, COVID 19 taught us how much we did not
know about navigating through a pandemic. But we did
learn and now have this knowledge to fall back on. If and
when we are presented with another situation, and as we
continue to navigate through this one, we would educate
ourselves as quickly as possible and take action. Our
country has learned, as have we, that you cannot sit idly by
and bury your head in the sand, only hoping for the best.
We will always prepare for the worse and hope for the best.
We have continued throughout this pandemic to treat our
patients and keep our office open with all the necessary
precautions and measures in place to keep our patients safe.
We offer telehealth for those who cannot physically present
for their appointments.
Timothy Keller
Chairman, and Founder
U.S. Diabetes Care
of Morristown
You cannot sit idly by
and bury your head in
the sand, only hoping
for the best.

My advice would first be to walk carefully and make sure
you have a solid foundation. Your foundation much
includes a solid financial foundation but also has
credentialing verified, have the proper staffing and
providers in place, and the proper number of providers – do
not overstaff. Make sure you have the patient base and then
add your providers. Make sure you have an experienced
billing and coding team in place and make sure your
insurance contracts are reimbursing adequately. Make sure
you do your homework on the services you are providing to
the patients and the community and that the service is
needed for. Also, keep in mind your referral sources need to
consistently be reminded you are here and you need to
thank them for referrals and provide patient feedback.
2022 and beyond?
I am the visionary of the company. I want to grow our
Morristown location with the number of patients we are
treating, along with the services we provide to the patients.
I want to be able to share the knowledge and services we
are providing across the country with other clinics through
distributorships. We will train them at our main Morristown
clinic and they will provide the same services in their own
clinics across the country.
Please give us a few testimonials of your recognitions
that accurately highlight your organization's position in
the market.
We won the 2021 Horizon Award through our local
Morristown Area Chamber of Commerce. The Horizon
Award is won and presented to a business five years or
newer showing tremendous potential for future growth and
success. This award is coveted by our team and something
we are very proud of being presented. There were a large
number of other companies that were potential winners of
this award, but U.S. Diabetes was chosen, which highlights
our position in the marketplace.
What is your opinion on the future of the healthcare
industry concerning patient preferences due to the
pandemic?
The expectation that patients will become increasingly
involved in making treatment decisions poses a new
challenge for providers. The population is increasingly
educated about disease treatments. This evolution stems
from various sociological changes. Part of this evolution
stems from various sociological changes. Part of this
requires a partnership to be forged between doctors and
patients. The patient will no longer accept solutions solely
based on what the doctor says. One of the challenges for
doctors is the time required.
A big advantage for U.S. Diabetes Care is that we spend a
large amount of time with our patients educating them and
focusing directly on their disease. This basically gives us an
opportunity to gain our patient's trust as we work with them
on their disease management and treatment. Also, there will
be the need to provide information or at least a path to find
information allowing the patients to help make medical
decisions. Some patients may be reluctant to be part of the
process.
In any event, the pandemic has changed our healthcare
world and forced us to make changes and will continue to
evolve as we face new challenges in healthcare.
August 2022

10 Most Trusted Diabetes Solution Providers in 2022V3 2.pdf

10 Most Trusted Diabetes Solution Providers in 2022V3 2.pdf

More Related Content

Similar to 10 Most Trusted Diabetes Solution Providers in 2022V3 2.pdf

More from insightscare

Recently uploaded

10 Most Trusted Diabetes Solution Providers in 2022V3 2.pdf